West Virginia NP's Drug Rx Rights Yanked by Inaction
Published Date: 7/16/2025
Notice
Summary
Osric Malone Prioleau, a nurse practitioner from West Virginia, lost his DEA registration because he no longer has state permission to handle controlled substances. He didn’t ask for a hearing, so the DEA officially revoked his registration as of early 2025. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Named Nurse
The Drug Enforcement Administration revoked DEA Certificate of Registration No. MM2233827 issued to Osric Malone Prioleau, N.P., and will deny any pending renewals or other registration applications in West Virginia. The Order is effective August 15, 2025; the record shows his West Virginia nursing licenses were suspended on August 22, 2024 and his DEA registration expired January 31, 2025. Mr. Prioleau may file a properly supported motion for reconsideration of the findings of fact within fifteen calendar days of the date of this Order.
DEA May Revoke When State License Suspended
The DEA states that it may suspend or revoke a practitioner's federal registration under 21 U.S.C. 824(a)(3) when the practitioner’s state license or registration has been suspended or revoked so the practitioner is no longer authorized to handle controlled substances under state law. The Agency also affirms it may adjudicate and enter final orders even where a DEA registration expired before the Order to Show Cause was issued.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-17276, Importer of Controlled Substances Application: Biopharmaceutical Research Company
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
2026-17285, Importer of Controlled Substances Application: Prof Compounding CTS of Ameri
Prof Compounding CTS of Ameri has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
2026-17275, Catina Allen, N.P.; Decision and Order
Catina Allen, a nurse practitioner from Indiana, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing to challenge this, so the DEA officially revoked her registration, which expired on June 30, 2026. This means she can’t prescribe or manage controlled drugs anymore, affecting her medical practice and patients.
2026-16665, Exempt Chemical Preparations Under the Controlled Substances Act
The applications for exempt chemical preparations received by the Drug Enforcement Administration between March 1, 2026, and June 30, 2026, as listed below, were accepted for filing and have been approved or denied as indicated. This publication addresses preparations through June 30, 2026, that were not included in previous Federal Register notices, and it does not affect preparations that have been previously published.
Previous / Next Documents
Previous: 2025-13315, Benson Sergiles, P.A.; Decision and Order
Benson Sergiles, P.A., a medical practice in Arizona, lost its DEA registration because it no longer has the state permission to handle controlled substances. Despite multiple attempts, the DEA couldn’t reach them for a hearing, so the registration was revoked by default. This means Benson Sergiles can’t legally manage controlled drugs anymore, effective immediately, impacting their business operations.
Next: 2025-13318, Revised Specification Pursuant to the Personal Responsibility and Work Opportunity Reconciliation Act of 1996
The Attorney General just updated a key rule from 2001 tied to the Personal Responsibility and Work Opportunity Act. This change affects agencies handling work and welfare programs, making sure the rules stay fresh and clear. No big money changes yet, but everyone should watch for new instructions soon.